Cynthia E. Fisher, MD, PhD
Associate Professor
Department of Medicine, Division of Allergy & Infectious Diseases
Research Associate
Vaccine & Infectious Disease Division (VIDD), Fred Hutchison Cancer Researcher Center

Faculty Information

Biography

Dr. Fisher specializes in the research and treatment of infectious diseases in organ transplant recipients and cancer patients. Specific areas of investigation include risk factors, prevention, diagnosis, and treatment of invasive fungal infections and respiratory viral infections. She also focuses on identifying underlying genetic factors that predispose patients to develop severe infections following transplantation.

Education & Training: 
MPH
John Hopkins Bloomberg, School of Public Health
Baltimore MD
2006
MD
John Hopkins Bloomberg, School of Public Health
Baltimore MD
2007
Residency
University of Pennsylvania
Philadelphia, PA
2007-2010
Fellowship in Infectious Diseases
University of Washington
Seattle WA
2010-2013
Honors: 
Phi Beta Kappa
2001
Merck Index Award, Top Chemistry/Biochemistry student at University of Washington
2002
O.C. Hubert Fellow in International Health, Centers of Disease Control
2006
Travel Grant, Infectious Disease Society of America
2012
Contact
Phone: 
(206) 598-9149
Mailing Address: 

1959 NE Pacific St.

Box 356174

Seattle, WA 98195

Publications
Publications: 

Seo S, Renaud C, Kuypers JM, Chiu CY, Huang M, Samayoa E, Xie H, Yu G, Fisher CE, Gooley T, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: Evidence of occult infectious etiologies. Blood. 2015 Jun 11; 125(24):3789-97.
PubMed Abstract

Preiksaitis CM, Kuypers JM, Fisher CE, Campbell AP, Jerome KR, Huang ML, Boeckh M, Limaye AP. A patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipients. J Clin Virol. 2015; 62:98-102.
 PubMed Abstract 

Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis. Transplant Infect Dis. 2014 Jun; 16(3):505-10.
PubMed Abstract

Fisher CE, Stevens AM, Boeckh M, Leisenring W, Pergam S, Hohl T. Degree of positivity of serum galactomannan is associated with higher mortality in HCT patients with invasive aspergillosis. Clin Infect Dis. 2013 Oct 1; 57(7):1001–1004.
PubMed Abstract